Yahoo奇摩 網頁搜尋

搜尋結果

  1. 2024年5月10日 · Novavax has signed a multi-billion dollar deal with French drugmaker Sanofi to co-commercialize Novavax's protein-based COVID-19 vaccine starting in 2025. Sanofi will pay Novavax an upfront ...

  2. 2024年5月10日 · Novavax shares soared after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Madison Muller reports on Bloomberg...

  3. 2024年5月14日 · Novavax Inc (NVAX) Compare Novavax Inc 14.22 +9.30% 14.22 market open • as of 20 May, 03:16 pm EDT +1.21 ( +9.30%) Summary Financials Analysis Earnings Investors Options Company History Related ...

  4. 2024年5月14日 · Analyst rating and price target. NVAX is rated "Buy" with a 12-month target price of 19.75, a ‎46.51% upside from the current price of 13.48. See more. Strong SellSell Hold Buy Strong Buy. Buy.

  5. 2024年5月17日 · The detail page will show you the real-time trend, you can click into the MSN Money website for more details NVAX Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology ...

  6. 2024年5月10日 · 10h • 1 min read. Novavax press release ( NASDAQ: NVAX ): Q1 GAAP EPS of -$1.05 beats by $0.01. Revenue of $94M (+16.0% Y/Y) misses by $7.45M. Cash, cash equivalents and restricted cash were ...

  7. 2024年5月6日 · By Bhanvi Satija. (Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the re-election of three directors and opposed proposals related to executive...

  1. 其他人也搜尋了